Loading clinical trials...
Loading clinical trials...
A Multi-centre, Randomized, Two-armed, Parallel Group and Evaluator-blinded Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Conditions
Interventions
MOB015B
Ciclopirox 80 mg/g
Locations
3
Germany
Multiple Locations, Germany
Multiple Locations, Poland
Multiple Locations, United Kingdom
Start Date
September 1, 2016
Primary Completion Date
June 10, 2020
Completion Date
June 10, 2020
Last Updated
October 6, 2020
Lead Sponsor
Moberg Pharma AB
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions